New Leaf Venture Partners, L.L.C. Buys Rallybio Corp, DICE Therapeutics Inc, Sierra Oncology Inc, Sells Arvinas Inc,

New York, NY, based Investment company New Leaf Venture Partners, L.L.C. (Current Portfolio) buys Rallybio Corp, DICE Therapeutics Inc, Sierra Oncology Inc, Renovacor Inc, Amryt Pharma PLC, sells Arvinas Inc, during the 3-months ended 2021Q3, according to the most recent filings of the investment company, New Leaf Venture Partners, L.L.C.. As of 2021Q3, New Leaf Venture Partners, L.L.C. owns 22 stocks with a total value of $347 million. These are the details of the buys and sells.

For the details of New Leaf Venture Partners, L.L.C.'s stock buys and sells, go to https://www.gurufocus.com/guru/new+leaf+venture+partners%2C+l.l.c./current-portfolio/portfolio

These are the top 5 holdings of New Leaf Venture Partners, L.L.C.
  1. Arvinas Inc (ARVN) - 1,308,187 shares, 31.01% of the total portfolio. Shares reduced by 40.88%
  2. Deciphera Pharmaceuticals Inc (DCPH) - 1,209,571 shares, 11.85% of the total portfolio.
  3. Rallybio Corp (RLYB) - 2,301,603 shares, 11.67% of the total portfolio. New Position
  4. Edgewise Therapeutics Inc (EWTX) - 1,553,661 shares, 7.44% of the total portfolio.
  5. Harpoon Therapeutics Inc (HARP) - 3,156,699 shares, 7.19% of the total portfolio.
New Purchase: Rallybio Corp (RLYB)

New Leaf Venture Partners, L.L.C. initiated holding in Rallybio Corp. The purchase prices were between $10.83 and $23.4, with an estimated average price of $14.65. The stock is now traded at around $15.000000. The impact to a portfolio due to this purchase was 11.67%. The holding were 2,301,603 shares as of 2021-09-30.

New Purchase: DICE Therapeutics Inc (DICE)

New Leaf Venture Partners, L.L.C. initiated holding in DICE Therapeutics Inc. The purchase prices were between $31.92 and $37, with an estimated average price of $34.06. The stock is now traded at around $29.410000. The impact to a portfolio due to this purchase was 5.26%. The holding were 556,693 shares as of 2021-09-30.

New Purchase: Sierra Oncology Inc (SRRA)

New Leaf Venture Partners, L.L.C. initiated holding in Sierra Oncology Inc. The purchase prices were between $16.4 and $23.1, with an estimated average price of $19.99. The stock is now traded at around $22.480000. The impact to a portfolio due to this purchase was 2.59%. The holding were 409,611 shares as of 2021-09-30.

New Purchase: Renovacor Inc (RCOR)

New Leaf Venture Partners, L.L.C. initiated holding in Renovacor Inc. The purchase prices were between $7.73 and $10.65, with an estimated average price of $9.33. The stock is now traded at around $8.870000. The impact to a portfolio due to this purchase was 1.82%. The holding were 697,436 shares as of 2021-09-30.

New Purchase: Amryt Pharma PLC (AMYT)

New Leaf Venture Partners, L.L.C. initiated holding in Amryt Pharma PLC. The purchase prices were between $9.63 and $12.47, with an estimated average price of $11.29. The stock is now traded at around $11.090700. The impact to a portfolio due to this purchase was 1.56%. The holding were 449,737 shares as of 2021-09-30.

Sold Out: (CHMA)

New Leaf Venture Partners, L.L.C. sold out a holding in . The sale prices were between $3.76 and $4.73, with an estimated average price of $4.31.



Here is the complete portfolio of New Leaf Venture Partners, L.L.C.. Also check out:

1. New Leaf Venture Partners, L.L.C.'s Undervalued Stocks
2. New Leaf Venture Partners, L.L.C.'s Top Growth Companies, and
3. New Leaf Venture Partners, L.L.C.'s High Yield stocks
4. Stocks that New Leaf Venture Partners, L.L.C. keeps buying